Search

Your search keyword '"Beyer-Westendorf J"' showing total 459 results

Search Constraints

Start Over You searched for: Author "Beyer-Westendorf J" Remove constraint Author: "Beyer-Westendorf J"
459 results on '"Beyer-Westendorf J"'

Search Results

1. Rivaroxaban for venous thromboembolism prevention after major orthopedic surgery: translating trial data into routine clinical practice

3. Efficacy and safety of venous thromboembolism prophylaxis with apixaban in major orthopedic surgery

5. Andexanet for Factor Xa Inhibitor-Associated Acute Intracerebral Hemorrhage.

7. Grundlagen zur Anwendung von Andexanet

9. OC 46.1 Absolute Quantitative Proteomics for Occult Cancer Screening in Patient with Unprovoked Venous Thromboembolism: Results from the Prospective PLATO-VTE Study

10. PB1080 Clinical Course and Management of Patients with Emergency Surgeries Treated with Direct Oral Anticoagulants or Vitamin K Antagonists – Results of the German Prospective RADOA-Registry

11. PB0479 The ABC-Bleeding Score for Prediction of On-Treatment Clinically Relevant Bleeding in Patients with Unprovoked Venous Thromboembolism: Results from the Prospective PLATO-VTE Study

15. Clinically relevant bleeding in cancer patients treated for venous thromboembolism from the CATCH study

22. Incidence and impact of anticoagulation-associated abnormal menstrual bleeding in women after venous thromboembolism

23. Cancer-Associated ThrOmboSIs – Patient-Reported OutcoMes With RivarOxaban (COSIMO) – Baseline characteristics and clinical outcomes

24. Patient-reported outcomes associated with changing to rivaroxaban for the treatment of cancer-associated venous thromboembolism – The COSIMO study

25. Anticoagulation treatment in cancer-Associated venous thromboembolism: Assessment of patient preferences using a discrete choice experiment (cosimo study)

26. SARS-CoV-2 Vaccine and Thrombosis: An Expert Consensus on Vaccine-Induced Immune Thrombotic Thrombocytopenia

28. Hematoma Expansion and Clinical Outcomes in Patients With Factor-Xa Inhibitor-Related Atraumatic Intracereoral Hemorrhage Treated Within the ANNEXA-4 Trial Versus Real-World Usual Care

29. Postthrombotic syndrome and quality of life after deep vein thrombosis in patients treated with edoxaban versus warfarin

32. The prognostic value of respiratory symptoms and performance status in ambulatory cancer patients and unsuspected pulmonary embolism; analysis of an international, prospective, observational cohort study

37. International longitudinal registry of patients with atrial fibrillation and treated with rivaroxaban: RIVaroxaban Evaluation in Real life setting (RIVER)

38. International longitudinal registry of patients with atrial fibrillation and treated with rivaroxaban: RIVaroxaban Evaluation in Real life setting (RIVER)

44. Restart of Anticoagulant Therapy and Risk of Thrombosis, Rebleeding, and Death after Factor Xa Inhibitor Reversal in Major Bleeding Patients

45. Heavy menstrual bleeding in women on anticoagulant treatment for venous thromboembolism: Comparison of high- and low-dose rivaroxaban with aspirin

49. Rivaroxaban for thromboprophylaxis after hospitalization for medical illness

50. Cancer associated thrombosis in everyday practice: perspectives from GARFIELD-VTE

Catalog

Books, media, physical & digital resources